Expertise in
16
conditions

Dr. Michael L. Scharf

Pulmonary Medicine
Jefferson University Physicians
211 S 9th St, Suite 401, 
Philadelphia, PA 
Expertise in
16
conditions
Jefferson University Physicians
211 S 9th St, Suite 401, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Scharf is a Pulmonary Medicine provider in Philadelphia, Pennsylvania. Dr. Scharf is highly rated in 16 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lung Metastases, Shoulder Arthroscopy, and Vertebroplasty.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in NJ
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

JEFFERSON UNIVERSITY PHYSICIANS
211 S 9th St, Suite 401, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drug: AV-101
Study Phase: Phase 2/Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

12 Total Publications

From Eyes to Airways: Comprehensive Imaging of Eosinophilic Angiocentric Fibrosis.
From Eyes to Airways: Comprehensive Imaging of Eosinophilic Angiocentric Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: July 28, 2025
Similar Doctors
Gerard J. Criner
Expertise in
34
conditions
Dr. Gerard J. Criner
Pulmonary Medicine
Expertise in
34
conditions
Dr. Gerard J. Criner
Pulmonary Medicine

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (4.0 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gerard Criner is a Pulmonary Medicine provider in Philadelphia, Pennsylvania. Dr. Criner is highly rated in 34 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, Lung Transplant, and Embolectomy.

Nathaniel T. Marchetti
Expertise in
18
conditions
Dr. Nathaniel T. Marchetti
Pulmonary Medicine
Expertise in
18
conditions
Dr. Nathaniel T. Marchetti
Pulmonary Medicine

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (4.0 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nathaniel Marchetti is a Pulmonary Medicine provider in Philadelphia, Pennsylvania. Dr. Marchetti is highly rated in 18 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Acute Interstitial Pneumonia, Lung Transplant, and Endoscopy.

Expertise in
15
conditions
Dr. Denis Hadjiliadis
Pulmonary Medicine
Expertise in
15
conditions
Dr. Denis Hadjiliadis
Pulmonary Medicine

Harron Lung Center Perelman

3400 Civic Center Boulevard, West Pavilion, 1st Floor, 
Philadelphia, PA 
 (2.0 miles away)
215-615-5864
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Denis Hadjiliadis is a Pulmonary Medicine provider in Philadelphia, Pennsylvania. Dr. Hadjiliadis is highly rated in 15 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Bronchiectasis, Allergic Bronchopulmonary Aspergillosis, Lung Transplant, and Advanced Bronchoscopy. Dr. Hadjiliadis is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Scharf's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile